2024-03-18 20:41:52 ET
Summary
- Performant Financial reported fourth quarter and full-year 2023 results largely in line with updated projections provided on the Q3 conference call in November.
- Healthcare revenues of $106.4 million increased by 12.4% year-over-year and represented 93.6% of total revenues, while Adjusted EBITDA of $3.3 million more than tripled.
- However, $4.1 million in capital expenditures resulted in slightly negative free cash flow for the year.
- On the conference call, management guided for another year of moderate growth in the core healthcare business and a slight improvement in Adjusted EBITDA.
- With potential earnings inflection still a couple of years in the future, I don't see any compelling reason to initiate new or add to existing positions at this point. Consequently, I am reiterating my "Hold" rating on the shares.
Note:
I have covered Performant Financial Corporation or "Performant Financial" ( PFMT ) previously, so investors should view this as an update to my earlier articles on the company. ...
Read the full article on Seeking Alpha
For further details see:
Performant Financial: No Earnings Inflection Anytime Soon, Hold